A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe

This study assessed the myocarditis and pericarditis reporting rate of the first dose of mRNA COVID-19 vaccines in Europe. Myocarditis and pericarditis data pertinent to mRNA COVID-19 vaccines (1 January 2021–11 February 2022) from EudraVigilance database were combined with European Centre for Disea...

Full description

Bibliographic Details
Main Authors:	Joana Tome, Logan T. Cowan, Isaac Chun-Hai Fung
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Microorganisms
Subjects:	COVID-19 adverse drug reaction myocarditis pericarditis COVID-19 mRNA vaccine
Online Access:	https://www.mdpi.com/2076-2607/11/5/1099

Similar Items

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01)

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
by: Ortal Tuvali, et al.
Published: (2022-04-01)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
by: Minghui Li, et al.
Published: (2021-10-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
by: Minglong Li, et al.
Published: (2022-08-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system
by: Congqin Chen, et al.
Published: (2022-09-01)

Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital
by: Mikel Urroz Elizalde, et al.
Published: (2024-02-01)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
by: Abdallah Alami, et al.
Published: (2022-05-01)

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
by: Zaeema Naveed, et al.
Published: (2024-03-01)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
by: Wei-Ju Su, et al.
Published: (2023-06-01)

COVID-19 VACCINE-ASSOCIATED MYOCARDITIS (RUSSIAN TRANSLATION)
by: M. C. Morgan, et al.
Published: (2022-12-01)

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
by: Sophie H. Bots, et al.
Published: (2022-11-01)

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
by: Rana I. Oueijan, et al.
Published: (2022-08-01)

Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy
by: Giovanni Corrao, et al.
Published: (2022-11-01)

Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination
by: Andrea Frustaci, et al.
Published: (2022-03-01)

Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
by: Bethlehem Mengesha, et al.
Published: (2022-04-01)

Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study
by: Guihong Liu, et al.
Published: (2023-12-01)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
by: Rima Hajjo, et al.
Published: (2021-10-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)

CMR Manifestations, Influencing Factors and Molecular Mechanism of Myocarditis Induced by COVID-19 Mrna Vaccine
by: Chao-Fei Ba, et al.
Published: (2022-10-01)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
by: Abdallah Alami, et al.
Published: (2023-07-01)

Post –acute sequalae of COVID-19 and cardiac outcomes in U. S. military members
by: Sithembile Mabila, et al.
Published: (2023-06-01)

Myopericarditis caused by severe acute respiratory syndrome coronavirus 2
by: İbrahim Ulaş Özturan, et al.
Published: (2020-12-01)

Clinical Characteristics of Patients with Myocarditis following COVID-19 mRNA Vaccination: A Systematic Review and Meta-Analysis
by: Reem H. Matar, et al.
Published: (2022-08-01)

Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
by: Ana I. Molina-Ramos, et al.
Published: (2022-11-01)

Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
by: Alessandra Piras, et al.
Published: (2022-09-01)

The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis
by: Antoine AbdelMassih, et al.
Published: (2022-11-01)

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
by: Lin YC, et al.
Published: (2023-10-01)

Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children
by: Trisha Patel, et al.
Published: (2022-05-01)

Soluble factors in COVID-19 mRNA vaccine-induced myocarditis causes cardiomyoblast hypertrophy and cell injury: a case report
by: Jose Gildardo Paredes-Vazquez, et al.
Published: (2023-09-01)

Case Report—<i>Escherichia coli</i> Pericarditis after Recent COVID-19 Pneumonia
by: Xinhang Tu, et al.
Published: (2023-06-01)

COVID-19 mRNA vaccine-related myocarditis: A PRISMA systematic review, imaging approach and differential diagnoses
by: Shaun Zhi Jie Yeo, MBChB, et al.
Published: (2024-03-01)

Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-1273) for males age 18–64 years
by: Osman N. Yogurtcu, et al.
Published: (2023-08-01)

One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
by: Matthew R. Petersen, et al.
Published: (2023-04-01)

COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature
by: Binita Bhandari, et al.
Published: (2021-05-01)